In 2013, Jonsson et al. reported that the presymptomatic presence of anti-SSA/Ro autoantibodies shows the highest odds ratio for the risk of development of pSS, followed by anti-SSB/La autoantibodies and ANA (15). This evidence concerns the gene SSB and peeling skin syndrome.